Protocol Review and Monitoring Committee

The National Cancer Institute (NCI) requires that all institutions with a designated cancer center have a Protocol Review and Monitoring Committee (PRMC) to oversee clinical research. The PRMC was established at UAMS in 1994 and reviews all clinical studies conducted under the auspices of the Winthrop P. Rockefeller Cancer Institute (Cancer Institute).

All cancer-related clinical protocols must be reviewed and receive full PRMC approval (in addition to IRB approval) before they can be activated and enroll patients. New protocols are approved based on scientific merit, scientific priority, patient availability, and available resources.

Contacts for administrative and data management questions, forms, and protocol submission:

Information for Patients ~ Information for Medical Professionals
Cancer Institute Research ~ About The Cancer Institute ~ Cancer Institute News and Events
How You Can Help ~ Search Our Site
Cancer Institute Home ~ UAMS Home

Legal Disclaimer
Notice of Privacy Practices

Winthrop P. Rockefeller Cancer Institute
4301 W. Markham St. #623
Little Rock, AR 72205
(501) 686-6000